Growth Metrics

Invivyd (IVVD) Cash & Current Investments (2020 - 2025)

Invivyd posted quarterly Cash & Current Investments of $226.7 million for Q4 2025, up 226.88% year-on-year from $69.3 million in Q4 2024, and up 166.8% on a QoQ basis from $85.0 million in Q3 2025.

Invivyd (IVVD) has 6 years of Cash & Current Investments data on file, last reported at $226.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 226.88% year-over-year to $226.7 million; the trailing twelve-month figure through Dec 2025 stood at $226.7 million (up 226.88% YoY), and the FY2025 full-year result was $226.7 million, up 226.88% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $226.7 million, up from $85.0 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $542.2 million in Q4 2021 and bottomed at $34.9 million in Q2 2025.
  • The 5-year median for Cash & Current Investments is $181.8 million (2023), against an average of $227.9 million.
  • The widest annual swing landed in 2021, when Cash & Current Investments jumped 371.55%; it then slumped 83.02% in 2022.
  • A 5-year view of Cash & Current Investments shows it stood at $542.2 million in 2021, then plunged by 83.02% to $92.1 million in 2022, then jumped by 117.91% to $200.6 million in 2023, then sank by 65.44% to $69.3 million in 2024, then soared by 226.88% to $226.7 million in 2025.
  • The last three Cash & Current Investments figures came in at $226.7 million (Q4 2025), $85.0 million (Q3 2025), and $34.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 Invivyd 208.38 Mn -18.31 Mn - 226.69 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 226.69 Mn
Sep 30, 2025 84.97 Mn
Jun 30, 2025 34.91 Mn
Mar 31, 2025 48.08 Mn
Dec 31, 2024 69.35 Mn
Sep 30, 2024 106.87 Mn
Jun 30, 2024 147.88 Mn
Mar 31, 2024 189.39 Mn
Dec 31, 2023 200.64 Mn
Sep 30, 2023 181.82 Mn
Jun 30, 2023 121.95 Mn
Mar 31, 2023 126.47 Mn
Dec 31, 2022 92.08 Mn
Sep 30, 2022 278.15 Mn
Jun 30, 2022 474.89 Mn
Mar 31, 2022 532.22 Mn
Dec 31, 2021 542.22 Mn
Sep 30, 2021 478.27 Mn
Jun 30, 2021 392.51 Mn
Dec 31, 2020 114.99 Mn